PubRank

C R Boland

Author PubWeight™ 99.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997 5.68
2 Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009 3.99
3 Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993 3.76
4 Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 1994 3.63
5 Conversion of diploidy to haploidy. Nature 2000 3.28
6 Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 1999 3.06
7 DNA repair and colorectal cancer. Gastroenterol Clin North Am 1996 2.88
8 Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995 2.62
9 Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 1996 2.37
10 BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer 2003 2.26
11 Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res 1995 2.17
12 Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A 1982 2.17
13 JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 1999 2.08
14 Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res 1997 1.96
15 Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 1998 1.90
16 Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996 1.74
17 Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 1996 1.73
18 Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 2001 1.70
19 JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 2000 1.68
20 Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 2000 1.66
21 JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut 2008 1.59
22 Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. J Clin Invest 1996 1.49
23 Regulation of canine gastric mucin synthesis and phospholipid secretion by acid secretagogues. Gastroenterology 1992 1.46
24 Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst 1997 1.40
25 Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 2001 1.36
26 Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001 1.33
27 A cancer-associated mucin alteration in benign colonic polyps. Gastroenterology 1982 1.33
28 Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res 2001 1.28
29 Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: early results of a prospective study. Gut 1984 1.26
30 Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 1998 1.22
31 Familial colonic cancer without antecedent polyposis. Ann Intern Med 1984 1.21
32 Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer 2003 1.21
33 Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest 1992 1.15
34 The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer 2001 1.13
35 Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem Biophys Res Commun 1992 1.12
36 Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene 1996 1.08
37 Microsatellites in the eukaryotic DNA mismatch repair genes as modulators of evolutionary mutation rate. Genome Res 2001 1.07
38 Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986 1.06
39 The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach. Aliment Pharmacol Ther 1996 1.05
40 Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci U S A 1996 1.05
41 Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001 1.04
42 Mucormycoma of the colon: early diagnosis and successful management. AJR Am J Roentgenol 1985 1.03
43 Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. Hepatology 1998 0.98
44 Glycoconjugates in the colons of New World monkeys with spontaneous colitis. Association between inflammation and neoplasia. Gastroenterology 1987 0.97
45 Localization of the Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23. Gastroenterology 1997 0.93
46 Colon cancer genetics. Cancer 1992 0.89
47 Regional differences in normal and cancer-associated glycoconjugates of the human colon. J Natl Cancer Inst 1985 0.89
48 Synthesis and prostaglandin E2-induced secretion of surfactant phospholipid by isolated gastric mucous cells. Gastroenterology 1991 0.88
49 The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116. Int J Cancer 1994 0.85
50 Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer. Cancer 1990 0.85
51 Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001 0.85
52 Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. Cancer Res 1992 0.83
53 Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res 1998 0.83
54 Antisense inhibition of hMLH1 is not sufficient for loss of DNA mismatch repair function in the HCT116+chromosome 3 cell line. Clin Cancer Res 2000 0.83
55 Liquid caustic ingestion. Spectrum of injury. Arch Intern Med 1980 0.82
56 Binding of lectins to goblet cell mucin in malignant and premalignant colonic epithelium in the CF-1 mouse. Gastroenterology 1985 0.81
57 Transitional mucosa of the colon and tumor growth factors. Med Hypotheses 1987 0.81
58 Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers. Br J Cancer 2013 0.80
59 Characteristics of colorectal carcinoma cells with high metastatic potential. Gastroenterology 1984 0.80
60 Analysis of cancer-associated colonic mucin by ion-exchange chromatography: evidence for a mucin species of lower molecular charge and weight in cancer. Biochim Biophys Acta 1989 0.78
61 Cancer-associated colonic mucin in cultured human tumor cells and athymic (nude) mouse xenografts. Cancer Res 1986 0.78
62 Multiple tumor suppressor genes in multistep carcinogenesis. Tohoku J Exp Med 1992 0.78
63 Glycoconjugate expression in normal, metaplastic, and neoplastic human upper gastrointestinal mucosa. J Clin Invest 1987 0.78
64 Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats. Gastroenterology 1996 0.77
65 Multistep progression of colorectal cancer in the setting of microsatellite instability: new details and novel insights. Gastroenterology 2001 0.77
66 JC virus: a biomarker for colorectal cancer? Med Hypotheses 2002 0.77
67 In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol Ther 2009 0.77
68 Comparison between transforming growth factor alpha and epidermal growth factor in the protection of rat gastric mucosa against drug-induced injury. Ital J Gastroenterol 1994 0.75
69 Fiber and colon cancer: the weight of the evidence. Gastroenterology 1992 0.75
70 Gastrin and colorectal neoplasia--chicken or egg, or both? J Clin Gastroenterol 1991 0.75
71 Pseudomyxoma peritonei. Radiologic features. J Clin Gastroenterol 1986 0.75
72 Rapid identification of RT-PCR clones containing translation-terminating mutations. Mutat Res 1997 0.75
73 Are lactating mothers a source of giardiasis? N Engl J Med 1982 0.75
74 Increased tumorigenicity after differentiation of colon cancer cell line: absence of association with mucin synthesis. Gastroenterology 1994 0.75
75 Role of prostaglandin E2 in cholinergic-mediated glycoprotein synthesis in canine antrum. Dig Dis Sci 1992 0.75
76 Hyperplastic polyps and colorectal cancer. Lancet 1983 0.75
77 Mucin glycoproteins in chronic ulcerative colitis. Peanut lectin binding in human and nonhuman primate colons. Dig Dis Sci 1985 0.75
78 Effect of sucralfate on components of mucosal barrier produced by cultured canine epithelial cells in vitro. Dig Dis Sci 1992 0.75
79 Passing the torch: a look back at our editorship. Gastroenterology 1996 0.75